(Q61873065)

English

Outcome of patients who develop acute leukemia or myelodysplasia as a second malignancy after solid tumors treated surgically or with strategies that include chemotherapy and/or radiation

scientific article published in 2008

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18286528%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Outcome of patients who develop acute leukemia or myelodysplasia as a second malignancy after solid tumors treated surgically or with strategies that include chemotherapy and/or radiation (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18286528%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

1 reference

based on heuristic

inferred from title

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18286528%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Suzanne Kamel-Reid

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18286528%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18286528%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

author name string

Arwa Abdelhameed

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18286528%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Nicholas Mitsakakis

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18286528%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Joseph Brandwein

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18286528%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Kathy Chun

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18286528%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Andre Schuh

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18286528%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Karen Yee

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18286528%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Gregory R Pond

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18286528%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Jeffrey H Lipton

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18286528%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Mark D Minden

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18286528%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Hans A Messner

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18286528%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

language of work or name

0 references

publication date

1 April 2008

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18286528%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18286528%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

112

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18286528%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18286528%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

1513-1521

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18286528%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Risk of leukemia after chemotherapy and radiation treatment for breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23325

7 January 2021

based on heuristic

inferred from DOI database lookup

Leukemia in breast cancer patients following adjuvant chemotherapy or postoperative radiation: the NSABP experience

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23325

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased intensification and total dose of cyclophosphamide in a doxorubicin-cyclophosphamide regimen for the treatment of primary breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-22

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23325

7 January 2021

based on heuristic

inferred from DOI database lookup

Further evaluation of intensified and increased total dose of cyclophosphamide for the treatment of primary breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-25

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23325

7 January 2021

based on heuristic

inferred from DOI database lookup

Second malignancies following CMF-based adjuvant chemotherapy in resectable breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23325

7 January 2021

based on heuristic

inferred from DOI database lookup

Secondary myelodysplastic syndrome/acute myeloid leukaemia following mitoxantrone-based therapy for breast carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23325

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment-related leukemia in breast cancer patients treated with fluorouracil-doxorubicin-cyclophosphamide combination adjuvant chemotherapy: the University of Texas M.D. Anderson Cancer Center experience

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23325

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk of acute leukemia following epirubicin-based adjuvant chemotherapy: a report from the National Cancer Institute of Canada Clinical Trials Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23325

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk of acute myeloid leukemia and myelodysplastic syndrome in trials of adjuvant epirubicin for early breast cancer: correlation with doses of epirubicin and cyclophosphamide

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23325

7 January 2021

based on heuristic

inferred from DOI database lookup

Therapy-related leukemia and myelodysplastic syndrome: clinical, cytogenetic, and prognostic features

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23325

7 January 2021

based on heuristic

inferred from DOI database lookup

Therapy-related acute promyelocytic leukemia with t(15;17) (q22;q12) following chemotherapy with drugs targeting DNA topoisomerase II. A report of two cases and a review of the literature

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23325

7 January 2021

based on heuristic

inferred from DOI database lookup

Pooled analysis of clinical and cytogenetic features in treatment-related and de novo adult acute myeloid leukemia and myelodysplastic syndromes based on a consecutive series of 761 patients analyzed 1976-1993 and on 5098 unselected cases reported i

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23325

7 January 2021

based on heuristic

inferred from DOI database lookup

Balanced chromosome abnormalities inv(16) and t(15;17) in therapy-related myelodysplastic syndromes and acute leukemia: report from an international workshop.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23325

7 January 2021

based on heuristic

inferred from DOI database lookup

21q22 balanced chromosome aberrations in therapy-related hematopoietic disorders: report from an international workshop

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23325

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: the University of Chicago series.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23325

7 January 2021

based on heuristic

inferred from DOI database lookup

Karyotype is an independent prognostic parameter in therapy-related acute myeloid leukemia (t-AML): an analysis of 93 patients with t-AML in comparison to 1091 patients with de novo AML

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23325

7 January 2021

based on heuristic

inferred from DOI database lookup

Secondary acute myeloid leukaemia: results of conventional treatments. Experience of GIMEMA trials

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23325

7 January 2021

based on heuristic

inferred from DOI database lookup

Therapy of secondary leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23325

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognosis in therapy-related acute myeloid leukemia and impact of karyotype

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23325

7 January 2021

based on heuristic

inferred from DOI database lookup

Allogeneic bone marrow transplantation for secondary leukaemia and myelodysplastic syndrome: a survey by the Leukaemia Working Party of the European Bone Marrow Transplantation Group (EBMTG)

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23325

7 January 2021

based on heuristic

inferred from DOI database lookup

Bone marrow transplantation for myelodysplasia and secondary acute nonlymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23325

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemotherapy only compared to chemotherapy followed by transplantation in high risk myelodysplastic syndrome and secondary acute myeloid leukemia; two parallel studies adjusted for various prognostic factors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23325

7 January 2021

based on heuristic

inferred from DOI database lookup

Adult acute lymphoblastic leukaemia.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23325

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduced-toxicity conditioning with treosulfan, fludarabine and ATG as preparative regimen for allogeneic stem cell transplantation (alloSCT) in elderly patients with secondary acute myeloid leukemia (sAML) or myelodysplastic syndrome (MDS).

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23325

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.23325

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18286528%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18286528%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q61873065&oldid=1531612817"